<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="section" /><meta name="keywords" content="Antibiotics see Antibacterials; Antibacterials: principles for selecting; Antibacterials: policies; Antibacterials: infections: oral; Infections: oropharyngeal: bacterial; Dental prescribing: infections: bacterial; Superinfection" /><meta name="IX" content="Antibacterials: policies; Antibacterials: infections: oral; Infections: oropharyngeal: bacterial; Dental prescribing: infections: bacterial; Superinfection" /><meta name="IXN" content="Antibiotics see Antibacterials" /><meta name="IXM" content="Antibacterials: principles for selecting" /><title>5.1 Antibacterial drugs: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="3705.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="3705.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=3705.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2071.htm">5 Infections</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="2071.htm" title="Previous: 5 Infections">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="104927.htm" title="Next: Table 1. Summary of antibacterial therapy">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1 id="_3705">5.1 Antibacterial drugs</h1><?highlighter on?><div id="pC" class="jN"><div><div class="cAZ"><h2>Choice of a suitable drug</h2> <p class="cAX">Before selecting an antibacterial the clinician must first consider
two factors—the patient and the known or likely causative organism.
Factors related to the patient which must be considered include history
of allergy, renal and hepatic function, susceptibility to infection
(i.e. whether immunocompromised), ability to tolerate drugs by mouth,
severity of illness, ethnic origin, age, whether taking other medication
and, if female, whether pregnant, breast-feeding or taking an oral
contraceptive.</p><p>The known or likely organism and its antibacterial sensitivity,
in association with the above factors, will suggest one or more antibacterials,
the final choice depending on the microbiological, pharmacological,
and toxicological properties.</p><p>An example of a rational approach to the selection of an antibacterial
is treatment of a urinary-tract infection in a patient complaining
of nausea and symptoms of a urinary-tract infection in early pregnancy.
The organism is reported as being resistant to <span>ampicillin</span> but sensitive to <span>nitrofurantoin</span> (can cause nausea), <span>gentamicin</span> (can be given only by injection and best avoided
in pregnancy), <span>tetracycline</span> (causes dental discoloration)
and <span>trimethoprim</span> (folate antagonist therefore theoretical
teratogenic risk), and <span>cefalexin</span>. The safest <span>antibiotics</span> in pregnancy are the penicillins and cephalosporins;
therefore, <span>cefalexin</span> would be indicated for this
patient.</p><p>The principles involved in selection of an antibacterial must
allow for a number of variables including changing renal and hepatic
function, increasing bacterial resistance, and information on side-effects.
Duration of therapy, dosage, and route of administration depend on
site, type and severity of infection and response.</p></div><div class="cAZ"><h2>Antibacterial policies</h2> <p class="cAX">Local policies often limit the
antibacterials that may be used to achieve reasonable economy consistent
with adequate cover, and to reduce the development of resistant organisms.
A policy may indicate a range of drugs for general use, and permit
other drugs only on the advice of the microbiologist or physician
responsible for the control of infectious diseases.</p></div><div class="cAZ"><h2>Before starting therapy</h2> <p class="cAX">The following precepts
should be considered before starting:</p><ul class="cBF"><li><p class="cQ">Viral infections should not be treated with antibacterials.
However, antibacterials may be used to treat secondary bacterial infection
(e.g. bacterial pneumonia secondary to influenza);</p></li><li><p class="cQ">Samples should be taken for culture and sensitivity testing; <b>‘blind’</b> antibacterial prescribing for unexplained pyrexia
usually leads to further difficulty in establishing the diagnosis;</p></li><li><p class="cQ">Knowledge of <b>prevalent organisms</b> and
their current sensitivity is of great help in choosing an antibacterial
before bacteriological confirmation is available. Generally, narrow-spectrum
antibacterials are preferred to broad-spectrum antibacterials unless
there is a clear clinical indication (e.g. life-threatening sepsis);</p></li><li><p class="cQ">The <b>dose</b> of an antibacterial varies according
to a number of factors including age, weight, hepatic function, renal
function, and severity of infection. The prescribing of the so-called
‘standard’ dose in serious infections may result in failure of treatment
or even death of the patient; therefore it is important to prescribe
a dose appropriate to the condition. An inadequate dose may also increase
the likelihood of antibacterial resistance. On the other hand, for
an antibacterial with a narrow margin between the toxic and therapeutic
dose (e.g. an aminoglycoside) it is also important to avoid an excessive
dose and the concentration of the drug in the plasma may need to be
monitored;</p></li><li><p class="cQ">The <b>route</b> of administration of an antibacterial
often depends on the severity of the infection. Life-threatening infections
require intravenous therapy. Antibacterials that are well absorbed
may be given by mouth even for some serious infections. Parenteral
administration is also appropriate when the oral route cannot be used
(e.g. because of vomiting) or if absorption is inadequate. Whenever
possible, painful intramuscular injections should be avoided in children;</p></li><li><p class="cQ"><b>Duration</b> of therapy depends on the nature
of the infection and the response to treatment. Courses should not
be unduly prolonged because they encourage resistance, they may lead
to side-effects and they are costly. However, in certain infections
such as tuberculosis or osteomyelitis it may be necessary to treat
for prolonged periods. Conversely a single dose of an antibacterial
may cure uncomplicated urinary-tract infections. The prescription
for an antibacterial should specify the duration of treatment or the
date when treatment is to be reviewed.</p></li></ul></div><div id="_3705.2"><div class="cAZ"><h2>Oral bacterial infections</h2> <p class="cAX">Antibacterial
drugs should only be prescribed for the <i>treatment</i> of oral infections on the basis of defined need. They may be used
in conjunction with (but not as an alternative to) other appropriate
measures, such as providing drainage or extracting a tooth.</p><p>The ‘blind’ prescribing of an antibacterial for unexplained
pyrexia, cervical lymphadenopathy, or facial swelling can lead to
difficulty in establishing the diagnosis. In severe oral infections,
a sample should always be taken for bacteriology.</p><p>Oral infections which may require antibacterial treatment include
acute periapical or periodontal abscess, cellulitis, acutely created
oral-antral communication (and acute sinusitis), severe pericoronitis,
localised osteitis, acute necrotising ulcerative gingivitis, and destructive
forms of chronic periodontal disease. Most of these infections are
readily resolved by the early establishment of drainage and removal
of the cause (typically an infected necrotic pulp). Antibacterials
may be required if treatment has to be delayed, in immunocompromised
patients, or in those with conditions such as diabetes or Paget’s
disease; see also Table 1, <a title="BNF:sub-topic: Ear, nose, and oropharynx" href="102044.htm#_102044">section 5.1</a>. Certain
rarer infections including bacterial sialadenitis, osteomyelitis,
actinomycosis, and infections involving fascial spaces such as Ludwig’s
angina, require antibiotics and specialist hospital care.</p><p>Antibacterial drugs may also be useful after dental surgery
in some cases of spreading infection. Infection may spread to involve
local lymph nodes, to fascial spaces (where it can cause airway obstruction),
or into the bloodstream (where it can lead to cavernous sinus thrombosis
and other serious complications). Extension of an infection can also
lead to maxillary sinusitis; osteomyelitis is a complication, which
usually arises when host resistance is reduced.</p><p>If the oral infection fails to respond to antibacterial treatment
within 48 hours the antibacterial should be changed, preferably on
the basis of bacteriological investigation. Failure to respond may
also suggest an incorrect diagnosis, lack of essential additional
measures (such as drainage), poor host resistance, or poor patient
compliance.  </p><p>Combination of a <span>penicillin</span> (or a macrolide) with <span>metronidazole </span>may sometimes be helpful
for the treatment of severe oral infections or oral infections that
have not responded to initial antibacterial treatment.</p><p>See also <span><b>Penicillins</b></span> (<a title="sub-section: Penicillins" href="3706.htm#_3706">section 5.1.1</a>), <span><b>Cephalosporins</b></span> (<a title="BNF:sub-sub-section: Cephalosporins" href="201577.htm#_201577">section 5.1.2</a>), <span><b>Tetracyclines</b></span> (<a title="sub-section: Tetracyclines" href="3804.htm#_3804">section 5.1.3</a>), <span><b>Macrolides</b></span> (<a title="sub-section: Macrolides" href="3849.htm#_3849">section 5.1.5</a>), <span><b>Clindamycin</b></span> (<a title="sub-section: Clindamycin" href="3863.htm#_3863">section 5.1.6</a>), <span><b>Metronidazole</b></span> (<a title="sub-section: Metronidazole and tinidazole" href="3931.htm#_3931">section 5.1.11</a>), <span><b>Fusidic acid</b></span> (<a title="sub-sub-section: Antibacterial preparations also used systemically" href="6134.htm#_6134">section 13.10.1.2</a>).</p></div></div><div class="cAZ"><h2>Superinfection</h2> <p class="cAX">In general, broad-spectrum antibacterial drugs such as the cephalosporins
are more likely to be associated with adverse reactions related to
the selection of resistant organisms e.g. <i>fungal infections</i> or <i>antibiotic-associated colitis</i> (pseudomembranous
colitis); other problems associated with superinfection include vaginitis
and pruritus ani.</p></div><div class="cAZ"><h2>Therapy</h2> <p class="cAX">Suggested treatment is shown in table
1. When the pathogen has been isolated treatment may be changed to
a more appropriate antibacterial if necessary. If no bacterium is
cultured the antibacterial can be continued or stopped on clinical
grounds. Infections for which prophylaxis is useful are listed in
table 2.</p></div></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_104927"><a href="104927.htm" title="Table 1. Summary of antibacterial therapy">Table 1. Summary of antibacterial therapy</a></li><li id="_104928"><a href="104928.htm" title="Table 2. Summary of antibacterial prophylaxis">Table 2. Summary of antibacterial prophylaxis</a></li><li id="_3706"><a href="3706.htm" title="5.1.1 Penicillins">5.1.1 Penicillins</a></li><li id="_3761"><a href="3761.htm" title="5.1.2 Cephalosporins, carbapenems, and other beta-lactams">5.1.2 Cephalosporins, carbapenems, and other beta-lactams</a></li><li id="_3804"><a href="3804.htm" title="5.1.3 Tetracyclines">5.1.3 Tetracyclines</a></li><li id="_3831"><a href="3831.htm" title="5.1.4 Aminoglycosides">5.1.4 Aminoglycosides</a></li><li id="_3849"><a href="3849.htm" title="5.1.5 Macrolides">5.1.5 Macrolides</a></li><li id="_3863"><a href="3863.htm" title="5.1.6 Clindamycin">5.1.6 Clindamycin</a></li><li id="_3866"><a href="3866.htm" title="5.1.7 Some other antibacterials">5.1.7 Some other antibacterials</a></li><li id="_3883"><a href="3883.htm" title="5.1.8 Sulfonamides and trimethoprim">5.1.8 Sulfonamides and trimethoprim</a></li><li id="_3899"><a href="3899.htm" title="5.1.9 Antituberculosis drugs">5.1.9 Antituberculosis drugs</a></li><li id="_3925"><a href="3925.htm" title="5.1.10 Antileprotic drugs">5.1.10 Antileprotic drugs</a></li><li id="_3931"><a href="3931.htm" title="5.1.11 Metronidazole and tinidazole">5.1.11 Metronidazole and tinidazole</a></li><li id="_3944"><a href="3944.htm" title="5.1.12 Quinolones">5.1.12 Quinolones</a></li><li id="_3960"><a href="3960.htm" title="5.1.13 Urinary-tract infections">5.1.13 Urinary-tract infections</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="2071.htm">Previous: 5 Infections</a> | <a class="top" href="3705.htm#">Top</a> | <a accesskey="]" href="104927.htm">Next: Table 1. Summary of antibacterial therapy</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>